What factors drive the cardiac valve repair devices market in MEA?

Mitral valve annuloplasty devices are expected to see the highest growth in the region.

Increased investments in healthcare infrastructure, advancements in medical research, and a growing elderly population are driving significant growth in the Middle East and Africa’s (MEA) cardiac valve repair devices market, according to GlobalData.

Rising awareness amongst patients and healthcare providers about treatment options is also contributing to the sector’s expansion.

“Valve repair is generally preferred over replacement for eligible patients due to its association with lower short-term and long-term mortality and morbidity rates,” said Thomas Fleming, Medical Analyst at GlobalData.

Mitral valve annuloplasty devices are expected to see the highest growth in MEA, with a compound annual growth rate exceeding 8% from 2024 to 2034.

“The growing prevalence of mitral valve regurgitation and valvular stenosis further supports the demand for repair devices,” Fleming added.

However, the analyst said the increasing adoption of transcatheter mitral valve repair and transcatheter aortic valve replacement devices could impact market dynamics.